192 related articles for article (PubMed ID: 8607184)
21. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
Arima T; Lehmann M; Flye MW
Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
[TBL] [Abstract][Full Text] [Related]
22. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses.
Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ
Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364
[TBL] [Abstract][Full Text] [Related]
23. Transgenic anti-CD4 monoclonal antibody secretion by mouse segmental pancreas allografts promotes long term survival.
Mottram PL; Murray-Segal LJ; Han W; Zhan Y; Brady JL; Lew AM
Transpl Immunol; 2000 Nov; 8(3):203-9. PubMed ID: 11147701
[TBL] [Abstract][Full Text] [Related]
24. MHC-identical heart and hepatocyte allografts evoke opposite immune responses within the same host.
Bumgardner GL; Gao D; Li J; Bickerstaff A; Orosz CG
Transplantation; 2002 Sep; 74(6):855-64. PubMed ID: 12364867
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection.
Pelletier R; Ohye R; Kincade P; Ferguson R; Orosz C
Transplant Proc; 1993 Feb; 25(1 Pt 1):839-41. PubMed ID: 7679845
[No Abstract] [Full Text] [Related]
26. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ
Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213
[TBL] [Abstract][Full Text] [Related]
27. Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment.
Sayegh MH; Sablinski T; Tanaka K; Kut JP; Kwok CA; Tilney NL; Kupiec-Weglinski JW; Milford EL
Transplantation; 1991 Feb; 51(2):296-9. PubMed ID: 1704648
[TBL] [Abstract][Full Text] [Related]
28. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats.
Yin DP; Sankary HN; Talor-Edwards C; Chong AS; Foster P; Shen J; Ma LL; Williams JW; Fathman CG
Transplantation; 1998 Jul; 66(1):1-5. PubMed ID: 9679814
[TBL] [Abstract][Full Text] [Related]
29. Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in mice.
Mottram PL; Pietersz GA; Smyth MJ; Purcell LJ; Clunie GJ; McKenzie IF
Transplantation; 1993 Mar; 55(3):484-90. PubMed ID: 8456465
[TBL] [Abstract][Full Text] [Related]
30. Experimental graft coronary artery disease in a murine heterotopic cardiac transplant model.
Hirozane T; Matsumori A; Furukawa Y; Sasayama S
Circulation; 1995 Jan; 91(2):386-92. PubMed ID: 7805242
[TBL] [Abstract][Full Text] [Related]
31. An increase in the survival of murine H-2-mismatched cultured fetal pancreas allografts using depleting or nondepleting anti-CD4 monoclonal antibodies, and a further increase with the addition of cyclosporine.
Burkhardt K; Charlton B; Mandel TE
Transplantation; 1989 May; 47(5):771-5. PubMed ID: 2655212
[TBL] [Abstract][Full Text] [Related]
32. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
33. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2.
Onodera K; Chandraker A; Volk HD; Ritter T; Lehmann M; Kato H; Sayegh MH; Kupiec-Weglinski JW
Transplantation; 1999 Jul; 68(2):288-93. PubMed ID: 10440403
[TBL] [Abstract][Full Text] [Related]
34. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
[TBL] [Abstract][Full Text] [Related]
35. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
Yuh DD; Morris RE
Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
[TBL] [Abstract][Full Text] [Related]
36. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model.
Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
Transplantation; 2003 May; 75(9):1475-81. PubMed ID: 12792500
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
[TBL] [Abstract][Full Text] [Related]
38. Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody.
Pearson TC; Bushell AR; Darby CR; West LJ; Morris PJ; Wood KJ
Clin Exp Immunol; 1993 May; 92(2):211-7. PubMed ID: 8097975
[TBL] [Abstract][Full Text] [Related]
39. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
[TBL] [Abstract][Full Text] [Related]
40. Immunosuppressive antibody treatment prolongs graft survival in two murine models of segmental pancreas transplantation.
Purcell LJ; Mottram PL; Mandel TE
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():349-52. PubMed ID: 8225401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
